Detalhe da pesquisa
1.
DNA Damage and Cancer Immunotherapy: A STING in the Tale.
Mol Cell
; 80(1): 21-28, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810436
2.
Long-Term Progression-Free Survival of a Pre-Treated Patient with Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil.
Chemotherapy
; 69(1): 27-34, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336201
3.
Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real-world data from the noninterventional TACTIC study in Germany.
Int J Cancer
; 153(6): 1227-1240, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37260368
4.
A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents.
Cancer Immunol Immunother
; 66(1): 129-140, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27858101
5.
Unresectable biliary tract cancer: Current and future systemic therapy.
Eur J Cancer
; 203: 114046, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626513
6.
BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors.
Nat Commun
; 10(1): 3143, 2019 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31316060
7.
Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance.
EMBO Mol Med
; 11(7): e9982, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31273933